Lidocaína Baxter (Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve and cardiac cell membranes, stabilising them in an inactive state. This prevents sodium influx, inhibiting the initiation and propagation of action potentials, which results in loss of sensation in peripheral nerves and reduced excitability of cardiac tissue.

The appropriate dose of Lidocaína Baxter is determined by the prescribing clinician based on the specific indication, patient characteristics, and clinical setting. Dosage regimens are individualized and should follow the prescriber’s instructions and local guidelines.

Safety data for lidocaine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To order Lidocaína Baxter, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lidocaine has a relatively rapid onset and moderate duration compared with agents such as bupivacaine, which lasts longer but has a slower onset. Lidocaine’s safety profile is well‑established, and it is often preferred for procedures requiring quick recovery of sensation.

Lidocaína Baxter should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight and extreme temperatures to maintain its stability and potency.

Lidocaína Baxter is administered intravenously, typically as a slow injection or infusion under continuous monitoring. The route allows rapid systemic distribution, making it suitable for both anesthetic and anti‑arrhythmic purposes.

Serious adverse events include seizures or convulsions, severe cardiac arrhythmias or cardiac arrest, and allergic reactions such as anaphylaxis. Prompt recognition and management of these events are essential during administration.

Patients with known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe hepatic impairment, and individuals with certain cardiac conduction disorders should avoid using Lidocaína Baxter unless specifically directed by a physician.